# EDGAR Filing Document

**Accession Number:** 0001524115
**File Stem:** 0001193125-25-186012
**Filing Date:** 2025-8
**Character Count:** 6943
**Document Hash:** 039c13e91dc8db3e6ef18c9e4f10679c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-186012.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001193125-25-186012

**CONFORMED SUBMISSION TYPE**: SC TO-I/A

**PUBLIC DOCUMENT COUNT**: 12

**FILED AS OF DATE**: 20250822

**DATE AS OF CHANGE**: 20250822

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Access Multi-Strategy Fund II
- **CENTRAL INDEX KEY:** 0001524115

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-86767
- **FILM NUMBER:** 251243733

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
- **BUSINESS PHONE:** 800-480-4111

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** J.P. Morgan Access Multi-Strategy Fund II
- **CENTRAL INDEX KEY:** 0001524115

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** SC TO-I/A

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
- **BUSINESS PHONE:** 800-480-4111

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE TO

TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)

OF THE SECURITIES EXCHANGE ACT OF 1934

(Final Amendment)

J.P. MORGAN ACCESS MULTI-STRATEGY FUND II

(Name of Subject Company (Issuer))

J.P. MORGAN ACCESS MULTI-STRATEGY FUND II

(Name of Filing Person(s) (Issuer))

SHARES OF BENEFICIAL INTEREST

(Title of Class of Securities)

N/A

(CUSIP Number of Class of Securities)

Abby L. Ingber, Esq.

c/o J.P. Morgan Private Investments Inc.

4 New York Plaza, Floor 19

New York, NY 10004

(800) 480-4111

(Name, Address and Telephone Number of Person Authorized to Receive Notices and

Communications on Behalf of the Filing Person(s))

With a copy to:

Stephen Cohen, Esq.

Dechert LLP

1900 K Street, NW

Washington, DC 20006

(202) 261-3304

March 28, 2025

(Date Tender Offer First Published,

Sent or Given to Security Holders)

------

☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐ third-party tender offer subject to Rule 14d-1.

☒ issuer tender offer subject to Rule 13e-4.

☐ going-private transaction subject to Rule 13e-3.

☐ amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☒

This final amendment relates to the Issuer Tender Offer Statement on Schedule TO (the "Statement") originally filed on March 28, 2025 by J. P. Morgan Access Multi-Strategy Fund II (the "Fund") in connection with an offer by the Fund (the "Offer") to purchase up to 35 percent of shares in the Fund ("Shares") on the terms and subject to the conditions set forth in the Offer to Purchase and the related Letter of Transmittal. Copies of the Offer to Purchase and Letter of Transmittal were previously filed as Exhibits B and C to the Statement on March 28, 2025.

This is the final amendment to the Statement and is being filed to report the results of the Offer. Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Offer to Purchase.

The following information is furnished pursuant to Rule 13e-4(c)(4):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Offer expired at 11:59 p.m., Eastern Time, on April 25, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The Valuation Date of the Shares tendered pursuant to the Offer was June 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Shares in the amount of $4,689,785.12 were validly tendered and not withdrawn prior to the expiration of the
Offer, and all of those Shares were accepted for purchase by the Fund in accordance with the terms of the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Payment of $4,455,243.96 was made via a non-interest bearing, non-transferable promissory note (the "Promissory Note."). The Fund paid to such tendering Shareholders the initial amount payable under the Note on August 14, 2025. The balance, if any, to be paid
to the tendering Shareholders with respect to the Shares purchased by the Fund, will be paid promptly after the completion of the Fund's audit for the fiscal year ended March 31, 2026. It is expected that the annual audit will be
completed no later than May 31, 2026.

Item 12. EXHIBITS

Calculation of Filing Fee Tables

------

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set out in this statement is true, complete and correct.

---

| | |
|:---|:---|
| J.P. MORGAN ACCESS MULTI-STRATEGY FUND II | J.P. MORGAN ACCESS MULTI-STRATEGY FUND II |
| By:  | /s/ Tricia Larkin |
|  | Name: Tricia Larkin |
|  | Title: Treasurer |

---

August 22, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

 **Calculation of Filing Fee Tables** <br>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Transaction Valuation**  | **Fee Rate**  | **Amount of Filing Fee**  |
| Fees to be Paid | 1 | $0.00 | 0.0001531 | $0.00 |
| Fees Previously Paid | 2 | $24316463.50 |  | $3722.85 |
|  | Total Transaction Valuation: | $24316463.50  |  |  |
|  | Total Fees Due for Filing: |  |  | $3722.85  |
|  | Total Fees Previously Paid:  |  |  | $3722.85  |
|  | Total Fee Offsets:  |  |  | $0.00  |
|  | Net Fee Due:  |  |  | $0.00  |

---

 **Offering Note** <br>

<sup>1</sup> Calculated at $153.10 per $1,000,000 of the Transaction Value.

<sup>2</sup> The transaction value is calculated as the aggregate maximum purchase price for Shares that could be purchased, based upon the shares outstanding and net asset value of the J.P. Morgan Access Multi-Strategy Fund II (the "Fund") as of January 31, 2025. The fee of $3,722.85 was paid in connection with the filing of the Schedule TO-I by the Fund (File No. 005-86767) on March 28, 2025 (the "Schedule TO"). This is the first amendment to the Schedule TO and is being filed to report the results of the Offer.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Fee Paid with Fee Offset Source |
| Fee Offset Claims | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fee Offset Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |

---